je.st
news
Tag: study
Insurers pay more tax on executive compensation under Obamacare: study
2014-08-27 07:05:41| Beverages - Topix.net
When Washington eliminated corporate tax deductions on health insurance executive compensation above $500,000 under President Barack Obama's healthcare reform law in 2013, it generated more than $72 million in additional tax revenue for the U.S. government, a left-leaning think tank said on Wednesday.
BASF study highlights the need for increased innovations to help feed the world
2014-08-27 06:00:00| Corn & Soybean Digest
BOONE, IA, August 27, 2014 – A majority of U.S. consumers and farmers agree that farmers are responsible for feeding the world and new technology and innovations are critical to achieving this goal. These findings were uncovered in the latest BASF Farm Perspectives Study, conducted in early 2014, comparing consumer and farmer viewpoints on agriculture-related issues. More than 9,000 people located in seven different countries participated in the study. read more
Bonanza for study of climate change's impact on marine methane
2014-08-27 00:39:00| Climate Ark Climate Change & Global Warming Newsfeed
Science Monitor: Methane streaming from the seafloor at ~425 meters (1400 ft) water depth offshore Virginia. Such naturally occurring methane seeps are a bonanza for scientists trying to understand undersea methane's responses to climate change. Researchers have discovered hundreds of naturally occurring methane seeps along the margins of the East Coast's continental shelf a bonanza for marine scientists trying to understand undersea methane's potential responses to climate change. In effect, these seeps...
CareTech Solutions Selected to Share Case Study at VMworld 2014
2014-08-26 18:11:30| IT Services - Topix.net
CareTech Solutions, an information technology and Web products and services provider for U.S. hospitals, announced today that the company will be presenting a case study at VMworld 2014, taking place Aug. 24-28 in San Francisco.
Tags: case
share
study
selected
Pfizer and Merck to Collaborate on Study Evaluating Novel Anti-Cancer Combination Regimen
2014-08-26 16:20:33| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Agreement to Combine Mercks Investigational Anti-PD-1 Antibody Pembrolizumab and Pfizers crizotinib (XALKORI) in Clinical Trial WHITEHOUSE STATION, N.J. Pfizer Inc. (NYSE:PFE) and Merck & Co. Inc. (NYSE: MRK), known as MSD outside the United States and Canada, through a subsidiary, announced today that they have entered into an agreement to explore the therapeutic potential of the combination of Pfizers crizotinib (XALKORI) with Mercks investigational anti-PD-1 antibody pembrolizumab, in a Phase 1b clinical study evaluating the safety and tolerability of the combination in patients with ALK-positive advanced or metastatic non-small cell lung cancer (NSCLC). Language: English read more
Tags: study
combination
evaluating
collaborate
Sites : [630] [631] [632] [633] [634] [635] [636] [637] [638] [639] [640] [641] [642] [643] [644] [645] [646] [647] [648] [649] next »